AXT INC - 8-K Filing

AXT, Inc. reports record Q3 2026 revenue of $73.4 million, up 162% year-over-year driven by indium phosphide demand. (Items: 2.02 Results of Operations and Financial Condition On October 29, 2026, AXT, Inc, 9.01 Financial Statements and Exhibits (d) Exhibits 99)

11 articles from 1 source · updated November 9, 2026, 12:20 UTC

Coverage

• Praxis Precision Medicines, Inc. - 8-K Filing SEC EDGAR · November 9, 2026, 12:02 UTC
• IONIS PHARMACEUTICALS INC - 8-K Filing SEC EDGAR · November 9, 2026, 12:00 UTC
• KKR & Co. Inc. - 8-K Filing SEC EDGAR · November 9, 2026, 11:51 UTC
• Freshworks Inc. - 8-K Filing SEC EDGAR · November 3, 2026, 21:20 UTC
• Alight, Inc. / Delaware - 8-K Filing SEC EDGAR · November 3, 2026, 21:18 UTC
• ADVANCED MICRO DEVICES INC - 8-K Filing SEC EDGAR · November 3, 2026, 21:16 UTC
• Guerrilla RF, Inc. - 10-Q Filing SEC EDGAR · November 2, 2026, 13:02 UTC
• Guerrilla RF, Inc. - 8-K Filing SEC EDGAR · November 2, 2026, 13:00 UTC
• Ingersoll Rand Inc. - 8-K Filing SEC EDGAR · October 29, 2026, 20:19 UTC
• TheRealReal, Inc. - 8-K Filing SEC EDGAR · October 29, 2026, 20:18 UTC
• AXT INC - 8-K Filing SEC EDGAR · October 29, 2026, 20:17 UTC